Girish S. Shroff, M. D.

Girish S. Shroff, M. D. has an extensive Medical career. Dr. Shroff began his Medical Training in India at the J. L. N. Medical College at Karnatak University where he received his M. B. B. S. degree in Medicine. Dr. Shroff performed a Medical Internship at the District Hospital of Belgaum, India and an Orthopedics Residency at the Bangalore Medical College in Bangalore, India. Dr. Shroff performed a Geriatrics Residency at Oak Forest Hospital in Oak Forest, Illinois and then went on to perform his Residency in Internal Medicine at the Finch University of Health Sciences/The Chicago Medical School in North Chicago, Illinois, where he was also a fourth year Chief Resident and then a Fellow in Cardiology. Dr. Shroff has received many Honors in his career including Distinction in Forensic Medicine and was awarded AMA/Burroughs Welcome Leadership Program. Dr. Shroff is Board Certified in Cardiovascular Disease. He is an active Member of the American Medical Association, American College of Cardiology and the Florida Medical Association.

Praveen K. Kanaparti, MD, FACC

Praveen K. Kanaparti, MD, FACC

Dr. Kanaparti received his MBBS and MD from Osmania University, Hyderabad, India. In the US, he completed his Residency in Internal Medicine and a Fellowship in Cardiology at Montefiore Medical Center/Albert Einstein College of Medicine, New York. There he received The Leo Davidoff Society award for outstanding achievement as a Resident.

For a year, he worked as an attending physician at Montefiore/North Central Bronx hospitals and conducted basic research on endothelial cell adhesion molecules and their role in Atherogenesis. Dr. Kanaparti has additional training in Cardiac MR and Cardiac CT from the University Of  Virginia.

He is proficient in performance of Cardiac Catheterization, temporary and permanent pacemaker implantation, Transthoracic & Transesophageal echocardiography and Echo-guided Pericardiocentesis. He is a member of American Heart Association, American Society of Nuclear Cardiology,  Society of Cardiac CT, Society of Cardiac MR, Society of Vascular Ultrasound and a Fellow of American college of cardiology. He is Board certified in Internal Medicine and in Cardiology.

Dr. Kanaparti became a Diplomate of the Certification Board of Cardiovascular Computed Tomography.

David J. Stroh, D. O.

David J. Stroh, D. O. has had a career in Medicine in Pulmonary/Critical Care and Cardiology as a civilian and as a Commander with the United States Navy.  Dr. Stroh obtained his Osteopathic Degree in Medicine from the Philadelphia College of Osteopathic Medicine in Philadelphia, Pennsylvania.  He performed his Internship at the Thomas Jefferson University Hospital.  Dr. Stroh performed his Residency at Mount Sinai Medical Center in Miami Beach, Florida.  His Fellowship in Pulmonary and Critical Care Medicine was performed at the University of Miami.  Dr. Stroh entered Naval Service in 1981 and attended Officer Indoctrination School in 1990.  He worked as a Staff Physician in Pulmonary/Critical Care and was a Cardiology Fellow at the Naval Hospital of San Diego from 1990-2000.  He worked as a Staff Physician in Cardiology at the Naval Hospital in Jacksonville, Florida from 2000-2002.   During his time in the Military, Dr. Stroh received many awards including:  Navy Commendation Medal with the Gold Star, Humanitarian Support Medal, Joint Meritorious Unit Commendation, National Defense Ribbon, and NATO Ribbon.  Dr. Stroh is Board Certified in Internal Medicine, Pulmonary Medicine, Critical Care, Cardiovascular Disease and is certified by the Certification Board of Nuclear Cardiology to practice Nuclear Cardiology.  Dr. Stroh is a Fellow with the American College of Physicians, a Fellow with the American College of Cardiology, a member of the Florida Osteopathic Medical Association and has been a member of the Association of Military Osteopathic Physicians and Surgeons.

Venkata S. Sagi, M. D.

Venkata S. Sagi, M. D. is a highly-specialized electrophysiologist and a well-respected expert in treating disorders of the heart’s electrical system. Dr. Sagi received his M. B. B. S. from Andhra Medical, Affiliate of University of Health Sciences in India where he finished in the top ten percent of his class. He performed his Internship at Andhra Medical before coming to the United States to perform his Residency in Internal Medicine and Fellowship in Electrophysiology at Wayne State University in Detroit, Michigan. Dr. Sagi performed additional Fellowships in Cardiology at Louisiana State University in Shreveport, Louisiana and in Electrophysiology at the University of Missouri at Kansas City/Mid-America Heart Institute in Kansas City, Missouri.

Dr. Sagi is Board Certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease and Clinical Cardiac Electrophysiology. He is a member of the American College of Cardiology and an affiliate member of the Heart Rhythm Society. During his graduate training, Dr. Sagi received awards for his performance as a Medical Intern and Resident. He has also been the recipient of the Edgar E Hull Award in Cardiology.

Dr. Sagi has performed thousands of procedures to successfully treat patients suffering from rhythm disturbances of the heart. Utilizing the latest state-of-the-art diagnostic techniques and therapies, Dr. Sagi is able to diagnose and treat even the most difficult cases of irregular heart beats.

Suzanne E Zentko, MD

Suzanne E Zentko, MD is a recent addition to the Southern Heart Group team. Dr. Zentko brings her excellent training and compassionate demeanor to the group and she has been extremely well received by patients and colleagues alike.

A native of the Pennsylvania area, Dr. Zentko completed her undergraduate degree with honors at Haverford College in Haverford, PA before attending medical school at the University of Pennsylvania School of Medicine. After obtaining her MD, Dr. Zentko performed her internal medicine residency at The Hospital of the University of Pennsylvania where she trained with top experts in the prevention, diagnosis, and treatment of adult diseases. As a cardiology fellow at Weill Cornell Medical Center, Dr. Zentko specialized in all aspects of non-invasive cardiology including nuclear cardiology, echocardiography, and cardiac ct angiography.

Dr. Zentko is well published and her work has been featured in national publications such as Emerging Concepts in Cardiology and the Journal of Thoracic and Cardiovascular Surgery.  Dr. Zentko is board certified in both internal medicine and cardiovascular disease and is a member of the Duval County Medical Society. She is a recipient of the NCI Research Fellowship Award and is a Fellow in Training of the American College of Cardiology.

Dr. Zentko is dedicated to her patients and to achieving the best possible outcome for each person entrusted to her care. She is friendly and compassionate and brings a personal touch to everything she does. With her exceptional training and soothing demeanor, Dr. Zentko will no doubt become a patient favorite and make an invaluable addition to Southern Heart Group.

Dr. Zentko is currently accepting new patients at our Baptist South location.

Ask a Question

Do you have a question for a physician or our office staff?

Please fill out the below contact form and we will reply to you shortly.

[contactform]

Myosin-Activating Agent Boosts Systolic Function, but Please Don’t Call it an “Inotrope”

www.theheart.org (read the full article)
September 26, 2008 | Steve Stiles

Toronto, ON – Would that which is called an inotrope, by any other name, be safer in heart failure? A small dose-ranging study in patients with stable heart failure supports animal research suggesting that an obscure drug, a selective activator of cardiac myosin, can amplify contractile function without increasing myocardial oxygen demand [1]. Investigators hope that CK-1827452 (Cytokinetics), as it’s called for now, will offer the benefits of conventional inotropic agents without the effects that can ultimately harm patients taking them.

They also don’t want the myosin activator, still technically a positive inotropic agent, to carry the drug class’s stigma by being lumped with 1-adrenergic agonists like dobutamine or phosphodiesterase-3 inhibitors like milrinone. Those drugs strengthen myocardial contractions and are used sparingly for short-term symptom relief in some high-risk populations, but at a high metabolic cost and increased arrhythmic and mortality risk.

Read full article…

Fish Oil Cut Heart Failure Morbidity, Death in GISSI-HF

In same study, statin showed no benefit.

Cardiology News (read full article)
Volume 6, Issue 9, Page 1 (September 2008)
BRUCE JANCIN (Denver Bureau)

MUNICH — Supplementation with a single daily low-dose fish oil capsule in patients with chronic heart failure resulted in modest but clinically meaningful reductions in mortality and cardiovascular hospitalization in a nearly 7,000-patient randomized trial presented at the annual congress of the European Society of Cardiology.

In a surprise finding, the same Italian study, known as GISSI-HF, concluded that rosuvastatin at 10 mg/day had no effect on mortality or hospital admission for cardiovascular events, suggesting that patients with chronic heart failure should not be started on statins. (See story on p. 9.)

In GISSI-HF, 6,975 patients with New York Heart Association class II-IV chronic heart failure were randomized in double-blind fashion to 1 g/day of omega-3 polyunsaturated fatty acids (n-3 PUFA) in the form of eicosapentaenoic acid and docosahexaenoic acid or to placebo. The participants were on standard background therapy with the agents of proven efficacy in heart failure.

All-cause mortality after a median 3.9 years of follow-up was 27% in the n-3 PUFA group and 29% in controls, for a significant adjusted 9% relative risk reduction in the n-3 PUFA group, reported Dr. Luigi Tavazzi, chair of the GISSI-HF steering committee and professor of cardiology at the University of Pavia (Italy).

The co-primary end point in GISSI-HF was death or cardiovascular hospitalization, which occurred in 57% of the n-3 PUFA cohort and in 59% of those on placebo, for an 8% relative risk reduction that did not reach statistical significance.

In all, 44 patients needed to be treated with n-3 PUFA for 3.9 years in order to prevent one additional death or cardiovascular hospitalization, whereas 56 patients needed to be treated in order to prevent one death. Those are fairly high numbers, but it’s a trouble-free therapy, according to Dr. Tavazzi.

Read the full article…

Baptist Medical Center – South

Our location at Baptist Medical Center SOUTH recently underwent an extensive expansion and features a beautiful, relaxing setting where patient comfort is the focus. For more information on the new office, please click here.

Address:
14546 Old St. Augustine Rd. , Suite 201
Jacksonville, Florida 32258

Phone: (904) 493-8001
Fax: (904) 493-8015

Office Manager: Sandra Commorato

Physicians:

David, J. Stroh, DO, FACC

Suzanne E. Zentko, MD

Paul H. Dillahunt, II, MD, FACC

Praveen K. Kanaparti, MD, FACC

Venkata Sagi, MD

 

Map:
View Larger Map

Fernandina Beach Office

Address:
1340 South 18th Street, Suite 202, Bldg. A
Fernandina Beach, Florida 32034

Phone: (904) 261-9786
Fax: (904) 261-6567

Office Manager: Jackie Plemmons

Physicians:

George G. Le-Bert, DO

Salvatore D. Diloreto, MD, FACC
Paul H. Dillahunt, II, MD, FACC
Russell B. Stapleton,III, MD, FACC
Girish S. Shroff, MD, FACC

Omar F. Dajani, MD, FACC

Venkata S. Sagi, MD

Map:

View Larger Map

« Previous Page — Next Page »